Literature DB >> 18443087

Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice.

Kathryn A Eaton1, David I Friedman, Gayle J Francis, Jessica S Tyler, Vincent B Young, Jennifer Haeger, Galeb Abu-Ali, Thomas S Whittam.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) is a food-borne pathogen that causes hemorrhagic colitis and acute renal failure. We used a germ-free mouse model to investigate the role of host factors, Shiga toxin 2 (Stx2), and bacterial strain in disease due to EHEC. Germ-free male and female Swiss-Webster mice that were 3 days to 12 weeks old were orally inoculated with 1 of 10 EHEC strains or derivatives of two of these strains with Stx2 deleted. All inoculated mice became infected regardless of the inoculum dose. All bacterial strains colonized the intestines, reaching levels of 10(9) to 10(12) CFU/g of feces by 4 days after inoculation. Seven of the 10 wild-type strains caused disease. However, the two Stx2 deletion mutants, unlike the Stx2(+) parental strains, did not cause disease. The clinical signs of disease in mice included lethargy, dehydration, polyuria, polydypsia, and death. Postmortem examination of affected mice revealed dehydration and luminal cecal fluid accumulation. Histologic examination revealed close adherence of bacteria to the intestinal epithelium in the ileum and cecum but not in the colon. Other lesions included progressive renal tubular necrosis, glomerular fibrin thrombosis, and red blood cell sludging. The severity of disease varied according to the bacterial strain and age, but not sex, of the host. This study demonstrated that EHEC colonizes germ-free mice in large numbers, adheres to the intestinal epithelium, and causes luminal cecal fluid accumulation and progressive renal failure. The disease in mice was Stx2 and bacterial strain dependent. This animal model should be a useful tool for studying the pathogenesis of renal disease secondary to EHEC infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443087      PMCID: PMC2446693          DOI: 10.1128/IAI.01626-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Virulence of Shiga toxin-producing Escherichia coli (STEC) in orally-infected mice correlates with the type of toxin produced by the infecting strain.

Authors:  A R Melton-Celsa; J E Rogers; C K Schmitt; S C Darnell; A D O'Brien
Journal:  Jpn J Med Sci Biol       Date:  1998

2.  The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression.

Authors:  Jessica S Tyler; Melissa J Mills; David I Friedman
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

3.  Analysis of the large bowel microbiota of colitic mice using PCR/DGGE.

Authors:  R Bibiloni; M A Simon; C Albright; B Sartor; G W Tannock
Journal:  Lett Appl Microbiol       Date:  2005       Impact factor: 2.858

4.  Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.

Authors:  Abhineet S Sheoran; Susan Chapman-Bonofiglio; Barrett R Harvey; Jean Mukherjee; George Georgiou; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 5.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts.

Authors:  H Michino; K Araki; S Minami; S Takaya; N Sakai; M Miyazaki; A Ono; H Yanagawa
Journal:  Am J Epidemiol       Date:  1999-10-15       Impact factor: 4.897

7.  Induction of glomerular lesions in the kidneys of mice infected with vero toxin-producing Escherichia coli by lipopolysaccharide injection.

Authors:  K Shimizu; K Tanaka; A Akatsuka; M Endoh; Y Koga
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

8.  Characteristic intestinal microflora of specific pathogen-free mice bred in two different colonies and their influence on postnatal murine immunocyte profiles.

Authors:  Taizo Nagura; Satoshi Hachimura; Shuichi Kaminogawa; Tsutomu Aritsuka; Kikuji Itoh
Journal:  Exp Anim       Date:  2005-04

9.  Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice.

Authors:  T Kurioka; Y Yunou; E Kita
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

10.  Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7.

Authors:  J W Conlan; M B Perry
Journal:  Can J Microbiol       Date:  1998-08       Impact factor: 2.419

View more
  43 in total

1.  Bifidobacteria can protect from enteropathogenic infection through production of acetate.

Authors:  Shinji Fukuda; Hidehiro Toh; Koji Hase; Kenshiro Oshima; Yumiko Nakanishi; Kazutoshi Yoshimura; Toru Tobe; Julie M Clarke; David L Topping; Tohru Suzuki; Todd D Taylor; Kikuji Itoh; Jun Kikuchi; Hidetoshi Morita; Masahira Hattori; Hiroshi Ohno
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

2.  Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice.

Authors:  Kathryn A Eaton; Alexander Honkala; Thomas A Auchtung; Robert A Britton
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  A Rare Opportunist, Morganella morganii, Decreases Severity of Polymicrobial Catheter-Associated Urinary Tract Infection.

Authors:  Brian S Learman; Aimee L Brauer; Kathryn A Eaton; Chelsie E Armbruster
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

4.  Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Cory M Robinson; Alison D O'Brien
Journal:  Vaccine       Date:  2010-05-14       Impact factor: 3.641

Review 5.  Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination.

Authors:  Stephanie J Dancer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Citrobacter rodentium Lysogenized with a Shiga Toxin-Producing Phage: A Murine Model for Shiga Toxin-Producing E. coli Infection.

Authors:  Laurice J Flowers; Shenglan Hu; Anishma Shrestha; Amanda J Martinot; John M Leong; Marcia S Osburne
Journal:  Methods Mol Biol       Date:  2021

Review 7.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

8.  Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections.

Authors:  Galeb S Abu-Ali; Lindsey M Ouellette; Scott T Henderson; David W Lacher; James T Riordan; Thomas S Whittam; Shannon D Manning
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

9.  Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse Model.

Authors:  Kakolie Goswami; Chun Chen; Lingzi Xiaoli; Kathryn A Eaton; Edward G Dudley
Journal:  Infect Immun       Date:  2015-08-10       Impact factor: 3.441

10.  A novel murine infection model for Shiga toxin-producing Escherichia coli.

Authors:  Emily M Mallick; Megan E McBee; Vijay K Vanguri; Angela R Melton-Celsa; Katherine Schlieper; Brad J Karalius; Alison D O'Brien; Joan R Butterton; John M Leong; David B Schauer
Journal:  J Clin Invest       Date:  2012-10-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.